Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07462507

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Led by Washington University School of Medicine · Updated on 2026-04-21

104

Participants Needed

1

Research Sites

376 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Adult patients with primary or secondary central nervous system malignancies will be invited to undergo a baseline \[C-11\]-CS1P1 PET scan and a follow-up scan within 24 months of the baseline scan (preferably within 6-months post-treatment).The study will describe patterns of tracer uptake in tumors and normal brain and explore how these patterns relate to MRI findings, treatments received, and clinical outcomes.

CONDITIONS

Official Title

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female, any race
  • Age 18 years or older
  • Able to provide written informed consent or have a legally authorized representative to consent
  • Clinical, radiographic, or pathological diagnosis of primary or secondary CNS malignancy not previously treated with radiotherapy
Not Eligible

You will not qualify if you...

  • Allergy to [C-11]-CS1P1 or its excipients
  • Contraindications to PET, CT, or MRI making participation unsafe
  • Prior cranial radiotherapy
  • Severe claustrophobia requiring general anesthesia
  • Currently pregnant or breastfeeding
  • Any condition increasing risk, limiting tolerance of procedures, or interfering with data collection (e.g., advanced kidney or liver failure)
  • Recent (within 12 months) participation in research involving radioactive agents exceeding regulatory radiation limits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

T

Tammie L.S. Benzinger, M.D., Ph.D.

CONTACT

J

Jayashree Rajamanickam

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here